â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

More documents

Recommendations

Info

ACCOUNTSPARENT COMPANY PROFIT AND LOSS STATEMENTNote 2000 1998/99(000)DKK(000)DKK7 monthsGROSS PROFIT 0 01 Administration expenses - 15,987 - 6,537OPERATING PROFIT - 15,987 - 6,5374 Share of result before tax in subsidiaries 5,032 - 19,0682 Financial income 2,443 2,3972 Financial expenses - 48,966 - 31,422RESULT BEFORE TAX - 57,478 - 54,6303 Income tax expenses 14,268 - 2,439NET RESULT - 43,210 - 57,069–54–
ACCOUNTSPARENT COMPANY BALANCE SHEETNoteASSETS31.12.00 31.12.99(000)DKK(000)DKKInvestments in subsidiaries 1,288,711 1,326,0824 Financial fixed assets 1,288,711 1,326,082TOTAL FIXED ASSETS 1,288,711 1,326,0825 Receivables from affiliated entities 8,542 78,8806 Other receivables 8,636 46,555Prepayments and accrued income 0 421Total receivables 17,178 125,856Cash 30,298 21,040TOTAL CURRENT ASSETS 47,476 146,896TOTAL ASSETS 1,336,187 1,472,978–55–
Page 2:
CONTENT ANNUAL REPORT3 This is Nyco
Page 6 and 7: KEY FIGURESDKK million 2000 1999 *)
Page 8 and 9: CHAIRMAN`s REPORTThe Board is very
Page 10 and 11: CHIEF EXECUTIVE OFFICER´s REPORTA
Page 12 and 13: CHIEF EXECUTIVE OFFICER´s REPORTfr
Page 14 and 15: BOARD OF DIRECTORS1092865131171241
Page 16 and 17: MANAGEMENTThe management group in N
Page 18 and 19: BUSINESS DESCRIPTIONNYCOMED MARKETS
Page 26 and 27: BUSINESS DESCRIPTIONMAIN PRODUCTSC
Page 28 and 29: BUSINESS DESCRIPTIONMAIN PRODUCTSTa
Page 30 and 31: BUSINESS DESCRIPTIONMAIN PRODUCTSNy
Page 32 and 33: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 34 and 35: BUSINESS DESCRIPTIONPRODUCT ORIGINA
Page 36 and 37: BUSINESS DESCRIPTIONQUALITY ASSURAN
Page 38 and 39: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 40 and 41: ACCOUNTSCHIEF FINANCIAL OFFICER`s R
Page 42 and 43: ACCOUNTSAUDITOR`s REPORT-40-
Page 44 and 45: ACCOUNTSACCOUNTING PRINCIPLESThe re
Page 46 and 47: ACCOUNTSACCOUNTING PRINCIPLESReceiv
Page 48 and 49: ACCOUNTSCONSOLIDATED BALANCE SHEETN
Page 50 and 51: ACCOUNTSCONSOLIDATED ACCOUNTS NOTES
Page 58 and 59: ACCOUNTSPARENT COMPANY BALANCE SHEE
Page 60 and 61: ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 62 and 63: ACCOUNTSPARENT COMPANY ACCOUNTS NOT
Page 64 and 65: ACCOUNTSOVERVIEW OF SUBSIDIARIESPar
Page 66 and 67: NYCOMED GROUP STRUCTURELEGAL STRUCT
Page 68 and 69: GermanyNycomed Pharma GmbHFraunhofe
show all

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

Create successful ePaper yourself

Delete template?

Save as template?

â rsrapport Nycomed - Takeda Pharmaceuticals International GmbH